10/870926International Classification: A61K031/4433, A61L009/04, A61K009/14U.S. Classification: 424046000, 514337000Abstract: The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, i